Huzhen Qingfeng Capsules | China Drugs List

Public reference information, not medical advice, a prescription or an offer to supply a medicine. Confirm current approval, availability and suitability with licensed professionals.

Medicine type
Traditional Chinese medicine
Therapeutic area
Immunology & rheumatology
Indications recorded in the public source
Traditional Chinese medicine (TCM) actions: clears heat and drains dampness, resolves blood stasis and turbidity, and nourishes the liver and kidney. Used for mild-to-moderate acute gouty arthritis with the TCM pattern of accumulated damp-heat, presenting with joint pain, swelling, heat and restricted movement, thirst, irritability or restlessness, a red tongue with a yellow or greasy yellow coating, and a slippery, rapid pulse.
Indication source and scope
Source date(s): 2025, 2026. Indications transcribed from the public NHSA manufacturer submission; this is not verification of the complete current label.
Prescribing-information limitations
A verifiable complete prescribing-information document has not yet been obtained. Available approval records or NHSA submissions support the indications shown; the latest full scope needs confirmation.
China availability status
Historical Chinese approval verified; current continuous market availability has not been checked for every product.
Overseas status
Market-by-market verification pending.
Insurance classification
Included in national insurance (Category B)
Insurance edition
2025 edition; effective 1 January 2026
Insurance restrictions
TCM actions: clears heat and drains dampness, resolves blood stasis and turbidity, and nourishes the liver and kidney. Limited to mild-to-moderate acute gouty arthritis with the TCM pattern of accumulated damp-heat, presenting with joint pain, swelling, heat and restricted movement, thirst, irritability or restlessness, a red tongue with a yellow or greasy yellow coating, and a slippery, rapid pulse.
Insurance period
2026-01-01 to 2027-12-31
Insurance verification notes
Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.

Sources

Open the interactive record, public price references and discussions